Strand V - Search Results

1

Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.

Orbai AM, de Wit M, Mease PJ, Callis Duffin K, Elmamoun M, Tillett W, Campbell W, FitzGerald O, Gladman DD, Goel N, Gossec L, Hoejgaard P, Leung YY, Lindsay C, Strand V, van der Heijde DM, Shea B, Christensen R, Coates L, Eder L, McHugh N, Kalyoncu U, Steinkoenig I, Ogdie A. Orbai AM, et al. Among authors: strand v. J Rheumatol. 2017 Oct;44(10):1522-1528. doi: 10.3899/jrheum.160904. Epub 2017 Feb 1. J Rheumatol. 2017. PMID: 28148697 Free PMC article.

2

OMERACT II: the biologics perspective.

Strand V. Strand V. J Rheumatol. 1995 Jul;22(7):1415-7. J Rheumatol. 1995. PMID: 7562788 Review.

3

Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.

Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, Altman R, Brandt K, Dougados M, Lequesne M. Bellamy N, et al. Among authors: strand v. J Rheumatol. 1997 Apr;24(4):799-802. J Rheumatol. 1997. PMID: 9101522 Review.

4

Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in Rheumatology.

Gazarian M, Tugwell P, Boers M, Bombardier C, Brooks P, Day R, Strand V, Wells G. Gazarian M, et al. Among authors: strand v. J Rheumatol. 1999 Jan;26(1):207-9. J Rheumatol. 1999. PMID: 9918265

5

Outcome measures to be used in clinical trials in systemic lupus erythematosus.

Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Strand V, et al. J Rheumatol. 1999 Feb;26(2):490-7. J Rheumatol. 1999. PMID: 9972993

6

Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains.

Smolen JS, Strand V, Cardiel M, Edworthy S, Furst D, Gladman D, Gordon C, Isenberg DA, Klippel JH, Petri M, Simon L, Tugwell P, Wolfe F. Smolen JS, et al. Among authors: strand v. J Rheumatol. 1999 Feb;26(2):504-7. J Rheumatol. 1999. PMID: 9972996

7

Imaging in rheumatoid arthritis: results of group discussions.

Molenaar ET, Boers M, van der Heijde DM, Alarcón G, Bresnihan B, Cardiel M, Edmonds J, Felson D, Furst DE, Kirwan J, Lassere M, Paulus H, Rau R, van Riel PL, Scott D, Simon L, Strand V. Molenaar ET, et al. Among authors: strand v. J Rheumatol. 1999 Mar;26(3):749-51. J Rheumatol. 1999. PMID: 10090196

8

Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology.

Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Strand V, et al. Lupus. 2000;9(5):322-7. doi: 10.1191/096120300678828424. Lupus. 2000. PMID: 10878722 Review.

9

Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.

Beaton DE, Bombardier C, Katz JN, Wright JG, Wells G, Boers M, Strand V, Shea B. Beaton DE, et al. Among authors: strand v. J Rheumatol. 2001 Feb;28(2):400-5. J Rheumatol. 2001. PMID: 11246687 Review.

10

Minimal clinically important differences: review of methods.

Wells G, Beaton D, Shea B, Boers M, Simon L, Strand V, Brooks P, Tugwell P. Wells G, et al. Among authors: strand v. J Rheumatol. 2001 Feb;28(2):406-12. J Rheumatol. 2001. PMID: 11246688 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

533 results

Search Page

Filters